BRIDGE PHARMA, INC. Patent applications |
Patent application number | Title | Published |
20150272941 | MEDICINAL TREATMENT OF CHRONIC PULMONARY INFLAMMATORY DISEASES WITH NORKETOTIFEN - The methods disclosed herein relate to the treatment of chronic pulmonary disorders, such as for example asthma, COPD, cough, bronchial hyperactivity and bronchitis, in human patients, by administering a therapeutically effective amount of RS-norketotifen. | 10-01-2015 |
20140120121 | MEDICINAL TREATMENT OF ATOPIC INFLAMMATORY DISEASES - The methods disclosed herein relate to the treatment of atopic inflammatory disorders, such as dermal or pulmonary atopic inflammatory disorders, in humans, by administering a therapeutically effective amount of ractopamine. | 05-01-2014 |
20140113936 | MEDICINAL TREATMENT OF DERMAL DISEASES IN COMPANION ANIMALS - The methods disclosed herein relate to the treatment of skin infections in dogs, by-administering a therapeutically effective amount of norketotifen. Therapeutic antimicrobial activity of norketotifen against | 04-24-2014 |
20130090295 | METHODS OF ACCELERATING MUSCLE GROWTH, DECREASING FAT DEPOSITS AND IMPROVING FEED EFFICIENCY IN LIVESTOCK ANIMALS - A method of promoting or improving the feed efficiency and the muscle to fat ratio in animals by administering to the animals a therapeutically effective amount of a pure or substantially pure RR-isomer of ractopamine is disclosed. Also disclosed are animal feed preparations and compositions and pharmaceutical preparations capable of increasing lean meat deposition in an animal or decreasing body fat, or promoting or improving the growth of an animal or improving the feed efficiency of an animal. Feed preparation, compositions and pharmaceutical preparations including therapeutically effective amounts of a pure or substantially pure RR-isomer of ractopamine are disclosed. | 04-11-2013 |
20120015895 | Use Of RR/SR-Ractopamine - A method of promoting or improving the feed efficiency and the muscle-to-fat ratio in animals by administering to the animals a therapeutically effective amount of a mixture of RR-ractopamine and SR-ractopamine is disclosed. Manufacturing methods for making RR/SR-ractopamine are presented. | 01-19-2012 |
20110294897 | Treating Xerophthalmia With Compounds Increasing Meibomian Gland Secretion - Methods for the treatment of patients suffering from dry eyes, by using adrenergic beta-receptor agonists, particularly salbutamol and in particular the optically pure or substantially pure R-enantiomer thereof. The embodiments disclosed herein include methods of increasing the Meibomian lipid secretion and thereby reducing or eliminating xerophthalmia symptoms by the administration of formulations containing therapeutically effective amounts of an adrenergic beta-receptor agonist to said patients. In particular, certain embodiments disclosed herein concern compositions that contain R-salbutamol as the active beta-receptor stimulating ingredient. In certain embodiments, the formulations are administered to the ocular surface of the eye and/or to the eyelid (the underside of the eyelid and/or the top of the eyelid) of a patient in need thereof. | 12-01-2011 |
20110218218 | Formulations Of Indanylamines And The Use Thereof As Local Anesthetics And As Medication For Chronic Pain - Internal-dermal formulations of RS—, S—, or R-2-[2-(N-phenyl-N-2-indanyl)aminoethyl]piperidine causing intradermal accumulation of said piperidine and intended for the treatment of neuropathic pain are provided, as well as a method of inducing the relief of pain using the compounds. | 09-08-2011 |
20100184865 | Use Of RR/SR-Ractopamine - A method of promoting weight loss in animals or humans by administering thereto a therapeutically effective amount of a mixture of RR-ractopamine and SR-ractopamine is disclosed. | 07-22-2010 |
20100179114 | S-Isomer of 2- piperidine and Other Dermal Anesthetic Agents - The present invention relates to the S-isomers of anesthetic compounds, the methods of treatment therewith, the compounds being useful for inducing local anesthesia, analgesia and sleep. | 07-15-2010 |
20100130550 | OCULAR FORMULATIONS OF NORKETOTIFEN - Ophthalmic compositions containing norketotifen and methods of making the same and the use thereof are disclosed. The methods also comprise administering to the eyes of a mammal in need thereof topical ophthalmic compositions containing norketotifen. | 05-27-2010 |
20090137628 | Formulations of Indanylamines and the Use Thereof as Local Anesthetics and as Medication for Chronic Pain - Dermal and mucosal formulations of 2-[2-(N-phenyl-N-2-indanyl)aminoethyl]piperidine, characterized by rapid dermal and mucosal absorption and long duration of therapeutic activity are provided. Also provided are solutions of 2-[2-(N-phenyl-N-2-indanyl)aminoethyl]piperidine for injection, characterized by short onset time and long duration of activity. Formulations containing both 2-[2-(N-phenyl-N-2-indanyl)aminoethyl]piperidine and capsaicin are also provided. | 05-28-2009 |